MYO
MYOMO, INC.
Overview
MYOMO, INC is a Healthcare company operating in Medical Devices with a $48.3M market cap.
MYO missed consensus EPS by 0.1% in Q1 FY2026, reported May 12, 2026.
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-0714 Q&A exchanges
- Q3 FY2025Earnings2025-11-1021 Q&A exchanges
- Q2 FY2025Earnings2025-08-1120 Q&A exchanges
- Q1 FY2025Earnings2025-05-0718 Q&A exchanges
- Q4 FY2024Earnings2025-03-1023 Q&A exchanges
- Q3 FY2024Earnings2024-11-0617 Q&A exchanges
- Q2 FY2024Earnings2024-08-0919 Q&A exchanges
- Q1 FY2024Earnings2024-05-0820 Q&A exchanges
- Q4 FY2023Earnings2024-03-0711 Q&A exchanges
- Q3 FY2023Earnings2023-11-0720 Q&A exchanges
- Q2 FY2023Earnings2023-08-0923 Q&A exchanges
- Q1 FY2023Earnings2023-05-185 Q&A exchanges
- Q4 FY2022Earnings2023-04-139 Q&A exchanges
- Q3 FY2022Earnings2022-11-106 Q&A exchanges
- Q2 FY2022Earnings2022-08-1113 Q&A exchanges
- Q1 FY2022Earnings2022-05-1210 Q&A exchanges
- Q4 FY2021Earnings2022-03-249 Q&A exchanges
- Q3 FY2021Earnings2021-11-0813 Q&A exchanges
- Q2 FY2021Earnings2021-08-1112 Q&A exchanges
- Q1 FY2021Earnings2021-05-126 Q&A exchanges
History
Earnings history
- Q1 FY20262026-05-12EPS$-0.09 vs $-0.09-5.8%Rev$10.1M vs ——EODHD
- Q4 FY20252026-03-15EPS$-0.09 vs $-0.08-1.4%Rev$11.4M vs ——EODHD
- Q3 FY20252025-11-09EPS$-0.09 vs $-0.11+18.2%Rev$10.1M vs ——EODHD
- Q2 FY20252025-08-10EPS$-0.12 vs $-0.10-20.0%Rev$9.7M vs ——EODHD
- Q1 FY20252025-05-05EPS$-0.08 vs $-0.10+20.0%Rev$9.8M vs ——EODHD
- Q4 FY20242025-03-04EPS$-0.01 vs $-0.02+57.1%Rev$12.1M vs ——EODHD
- Q3 FY20242024-11-05EPS$-0.03 vs $-0.04+25.0%Rev$9.2M vs ——EODHD
- Q2 FY20242024-08-05EPS$-0.03 vs $-0.07+57.1%Rev$7.5M vs ——EODHD
- Q1 FY20242024-05-07EPS$-0.10 vs $-0.100.0%Rev$3.8M vs ——EODHD
- Q4 FY20232024-03-06EPS$-0.07 vs $-0.06-16.7%Rev$4.8M vs ——EODHD
- Q3 FY20232023-11-06EPS$-0.06 vs $-0.09+33.3%Rev$5.1M vs ——EODHD
- Q2 FY20232023-08-08EPS$-0.04 vs $-0.03-33.3%Rev$6.0M vs ——EODHD
- Q1 FY20232023-05-09EPS$-0.11 vs $-0.13+15.4%Rev$3.4M vs ——EODHD
- Q4 FY20222023-03-12EPS$-0.29 vs $-0.42+30.9%Rev$4.0M vs ——EODHD
- Q3 FY20222022-11-09EPS$-0.40 vs $-0.43+7.0%Rev$4.0M vs ——EODHD
- Q2 FY20222022-08-02EPS$-0.42 vs $-0.43+2.3%Rev$3.7M vs ——EODHD
- Q1 FY20222022-05-10EPS$-0.41 vs $-0.53+22.6%Rev$3.9M vs ——EODHD
- Q4 FY20212022-03-08EPS$-0.52 vs $-0.49-6.1%Rev$4.0M vs ——EODHD
- Q3 FY20212021-11-09EPS$-0.36 vs $-0.46+21.7%Rev$4.4M vs ——EODHD
- Q2 FY20212021-08-08EPS$-0.46 vs $-0.60+23.3%Rev$3.1M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | 2026-05-12 | $-0.09 | $-0.09 | -5.8% | $10.1M | — | — | EODHD |
| Q4 FY2025 | 2026-03-15 | $-0.09 | $-0.08 | -1.4% | $11.4M | — | — | EODHD |
| Q3 FY2025 | 2025-11-09 | $-0.09 | $-0.11 | +18.2% | $10.1M | — | — | EODHD |
| Q2 FY2025 | 2025-08-10 | $-0.12 | $-0.10 | -20.0% | $9.7M | — | — | EODHD |
| Q1 FY2025 | 2025-05-05 | $-0.08 | $-0.10 | +20.0% | $9.8M | — | — | EODHD |
| Q4 FY2024 | 2025-03-04 | $-0.01 | $-0.02 | +57.1% | $12.1M | — | — | EODHD |
| Q3 FY2024 | 2024-11-05 | $-0.03 | $-0.04 | +25.0% | $9.2M | — | — | EODHD |
| Q2 FY2024 | 2024-08-05 | $-0.03 | $-0.07 | +57.1% | $7.5M | — | — | EODHD |
| Q1 FY2024 | 2024-05-07 | $-0.10 | $-0.10 | 0.0% | $3.8M | — | — | EODHD |
| Q4 FY2023 | 2024-03-06 | $-0.07 | $-0.06 | -16.7% | $4.8M | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $-0.06 | $-0.09 | +33.3% | $5.1M | — | — | EODHD |
| Q2 FY2023 | 2023-08-08 | $-0.04 | $-0.03 | -33.3% | $6.0M | — | — | EODHD |
| Q1 FY2023 | 2023-05-09 | $-0.11 | $-0.13 | +15.4% | $3.4M | — | — | EODHD |
| Q4 FY2022 | 2023-03-12 | $-0.29 | $-0.42 | +30.9% | $4.0M | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-0.40 | $-0.43 | +7.0% | $4.0M | — | — | EODHD |
| Q2 FY2022 | 2022-08-02 | $-0.42 | $-0.43 | +2.3% | $3.7M | — | — | EODHD |
| Q1 FY2022 | 2022-05-10 | $-0.41 | $-0.53 | +22.6% | $3.9M | — | — | EODHD |
| Q4 FY2021 | 2022-03-08 | $-0.52 | $-0.49 | -6.1% | $4.0M | — | — | EODHD |
| Q3 FY2021 | 2021-11-09 | $-0.36 | $-0.46 | +21.7% | $4.4M | — | — | EODHD |
| Q2 FY2021 | 2021-08-08 | $-0.46 | $-0.60 | +23.3% | $3.1M | — | — | EODHD |
Source: EODHD. MYO reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks MYO's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 90% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.72 | $2.28 | +19.4% | -2.6% | -5.2% |
| Q4 FY2026 | $2.92 | $2.55 | +14.6% | +2.6% | -0.2% |
| Q3 FY2026 | $3.14 | $2.58 | +21.8% | +0.1% | -2.2% |
| Q2 FY2026 | $2.96 | $2.48 | +19.2% | +1.8% | -0.7% |
| Q1 FY2025 | $2.79 | $2.45 | +14.0% | +0.3% | -2.2% |
| Q4 FY2025 | $2.75 | $2.42 | +13.6% | +2.5% | +3.6% |
| Q3 FY2025 | $2.90 | $2.49 | +16.5% | +3.0% | +3.0% |
| Q2 FY2025 | $3.18 | $2.52 | +26.0% | +1.7% | +2.9% |
| Q1 FY2024 | $2.82 | $2.50 | +12.8% | +5.9% | +6.3% |
| Q4 FY2024 | $3.19 | $2.63 | +21.2% | +6.1% | +6.4% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Paul R GudonisCEO1 yr 3 mo11 callsCurrentSample
CEO since 2025 • 2/4 beats (50%) • last guidance cut Q2 FY2026
- David A HenryCFO1 yr 3 mo4 callsCurrentSample
CFO since 2025 • 2/4 beats (50%) • last guidance cut Q3 FY2026
- Harry KovelmanChief Medical Officer1 yr 3 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • last call held guidance Q3 FY2026
- Micah MitchellChief Commercial Officer1 yr 3 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance raise Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MYO.
$ curl https://api.spokenalpha.com/v1/companies/MYOFAQ
Frequently asked about MYO
Where can I find MYOMO, INC.'s (MYO) earnings call transcripts?
Spoken Alpha indexes MYO's earnings call transcripts at https://spokenalpha.com/companies/MYO. Each call links to attributed speakers and parsed analyst Q&A. MYOMO, INC.'s own investor relations page is at https://ir.myomo.com/.
When was MYOMO, INC.'s most recent earnings call?
MYOMO, INC. (MYO) held its most recent earnings call on 2026-05-07, covering fiscal Q1 2026.
What sector is MYO in?
MYOMO, INC. (MYO) operates in the Healthcare sector (Medical Devices industry).